LongCovid
New relevant publication on The Lancet!
“An inhaled Covid vaccine booster was more than 5-fold effective for inducing neutralizing antibodies at 28-days, and more durable at 1-year, than shots, vs Omicron BA.5 in a randomized trial”.
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial – The Lancet Infectious Diseases
Do not miss this very interesting article published by The Intelligencer (New York Magazine) about Lisa Sanders, internal-medicine doctor at Yale University School of Medicine, and her job at…
The World Health Organization has joined the US CDC and HHS in providing new guidance on the ongoing public health threat posed by Long Covid. World Health Organization…
The BMJ Medicine journal just published two papers (a new study led by Université Paris Cité and Université Sorbonne Paris Nord, and a systematic review carried out by Bond University) with evidences…
This recent study showed that myricetin (3,5,7-trihydroxy-2-(3,4,5-tri hydroxyphenyl)-4-benzopyrone), a common flavonol extracted from many natural plants and Chinese herb medicines, is able to inhibit binding between the receptor…